Parameter
| Biomarker | MUC5AC+MUC2+MUC1 | Full name | Mucin 5AC + Mucin 2 + Mucin 1 | Molecular Type | Protein combination |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | A premalignant lesion progression prediction | ||
| Disease | Pancreatic Cancer | Disease Subtypes | / | ||
| Organ | Pancreas | Test Sample / Technology Platform | Tissue (immunohistochemistry) | ||
| Pathobiological Mechanisms | Members of the family of mucin MUC5AC and MUC2 expression in noninvasive MCN, (MUC1) expression is associated with invasive characteristics | ||||
| Clinical Availability Status | Clinical research phase: used to assess the risk of progression of MCN, guiding surgical intervention in time | ||||
| Notes and Dynamics | It can be used to distinguish non-invasive and invasive MCN, provide molecular basis for clinical decision-making, and avoid overtreatment or undertreatment | ||||